Sharma, Nikita S.
Gnamlin, Prisca
Durden, Brittany
Gupta, Vineet K.
Kesh, Kousik
Garrido, Vanessa T.
Dudeja, Vikas
Saluja, Ashok
Banerjee, Sulagna
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01-CA184274)
Article History
Received: 24 June 2019
Revised: 23 October 2019
Accepted: 28 October 2019
First Online: 18 November 2019
Conflict of interest
: University of Minnesota has a patent for Minnelide, which has been licensed to Minneamrita Therapeutics, LLC. A.K.S. is the co-founder and the Chief Scientific Officer of this company. S.B. is a consultant with Minneamrita Therapeutics LLC and this relationship is managed by University of Miami. The remaining authors declare no conflict of interest.